Advertisement
Screener

AGENUS INC (AGEN) Increase (Decrease) in Other Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

AGENUS INC Increase (Decrease) in Other Accounts Payable and Accrued Liabilities

AGENUS INC (AGEN) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$2.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-07

  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $202.00K, a 92.91% decline year-over-year.
  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$3.08M, a 323.35% decline year-over-year.
  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$8.94M.
  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $9.21M, a 336.67% increase year-over-year.
  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $4.50M, a 3208.09% increase from fiscal 2024.
  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was $136.00K, a 99.34% decline from fiscal 2023.
  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was $20.61M, a 913.42% increase from fiscal 2022.
  • AGENUS INC increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was $2.03M.
Period endIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filedIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filedIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month as first filedIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 12 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month as first filed
2026-06-30$202.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$2.88M
10-Q · filed 2026-08-07
-$11.81M
derived: sum of 3 quarters · filed 2026-08-07
-$2.61M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$3.08M
10-Q · filed 2026-05-11
-$12.02M
derived: sum of 2 quarters · filed 2026-05-11
-$2.81M
derived: sum of 3 quarters · filed 2026-05-11
$40.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$8.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$269.00K
derived: sum of 2 quarters · filed 2026-03-16
$3.12M
derived: sum of 3 quarters · filed 2026-08-07
$4.50M
10-K · filed 2026-03-16
2025-09-30$9.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$12.06M
derived: sum of 2 quarters · filed 2026-08-07
$13.44M
10-Q · filed 2025-11-10
$11.85M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$2.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$4.23M
10-Q · filed 2026-08-07
$2.64M
derived: sum of 3 quarters · filed 2026-08-07
$4.75M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$1.38M
10-Q · filed 2026-05-11
-$207.00K
derived: sum of 2 quarters · filed 2026-05-11
$1.90M
derived: sum of 3 quarters · filed 2026-05-11
$5.14M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$1.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$522.00K
derived: sum of 2 quarters · filed 2026-03-16
$3.76M
derived: sum of 3 quarters · filed 2026-03-16
$136.00K
10-K · filed 2026-03-16
2024-09-30$2.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$5.34M
derived: sum of 2 quarters · filed 2025-11-10
$1.72M
10-Q · filed 2025-11-10
$9.82M
derived: sum of 4 quarters · filed 2026-03-16
2024-06-30$3.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$386.00K
10-Q · filed 2025-08-11
$7.71M
derived: sum of 3 quarters · filed 2026-03-16
$12.09M
derived: sum of 4 quarters · filed 2026-03-16
2024-03-31-$3.62M
10-Q · filed 2025-05-12
$4.47M
derived: sum of 2 quarters · filed 2026-03-16
$8.86M
derived: sum of 3 quarters · filed 2026-03-16
$11.83M
derived: sum of 4 quarters · filed 2026-03-16
2023-12-31$8.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$12.48M
derived: sum of 2 quarters · filed 2026-03-16
$15.46M
derived: sum of 3 quarters · filed 2026-03-16
$20.61M
10-K · filed 2026-03-16
2023-09-30$4.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$7.36M
derived: sum of 2 quarters · filed 2024-11-12
$12.52M
10-Q · filed 2024-11-12
$17.08M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30$2.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$8.13M
10-Q · filed 2024-08-08
$12.69M
derived: sum of 3 quarters · filed 2025-03-17
$11.72M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31$5.16M
10-Q · filed 2024-05-07
$9.72M
derived: sum of 2 quarters · filed 2025-03-17
$8.74M
derived: sum of 3 quarters · filed 2025-03-17
$6.91M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31$4.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
$3.59M
derived: sum of 2 quarters · filed 2025-03-17
$1.75M
derived: sum of 3 quarters · filed 2025-03-17
$2.03M
10-K · filed 2025-03-17
2022-09-30-$971.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$2.80M
derived: sum of 2 quarters · filed 2023-11-09
-$2.52M
10-Q · filed 2023-11-09
$7.59M
derived: sum of 4 quarters · filed 2024-03-14
2022-06-30-$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$1.55M
10-Q · filed 2023-08-08
$8.57M
derived: sum of 3 quarters · filed 2024-03-14
-$6.11M
derived: sum of 4 quarters · filed 2024-03-14
2022-03-31$279.00K
10-Q · filed 2023-05-09
$10.40M
derived: sum of 2 quarters · filed 2024-03-14
-$4.28M
derived: sum of 3 quarters · filed 2024-03-14
-$3.04M
derived: sum of 4 quarters · filed 2024-03-14
2021-12-31$10.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$4.56M
derived: sum of 2 quarters · filed 2024-03-14
-$3.32M
derived: sum of 3 quarters · filed 2024-03-14
-$1.06M
10-K · filed 2024-03-14
2021-09-30-$14.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$13.44M
derived: sum of 2 quarters · filed 2022-11-08
-$11.18M
10-Q · filed 2022-11-08
$1.39M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$3.50M
10-Q · filed 2022-08-09
$16.07M
derived: sum of 3 quarters · filed 2023-03-16
$10.85M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31$2.25M
10-Q · filed 2022-05-10
$14.83M
derived: sum of 2 quarters · filed 2023-03-16
$9.61M
derived: sum of 3 quarters · filed 2023-03-16
$14.55M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31$12.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$7.36M
derived: sum of 2 quarters · filed 2023-03-16
$12.30M
derived: sum of 3 quarters · filed 2023-03-16
$3.83M
10-K · filed 2023-03-16
2020-09-30-$5.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$277.00K
derived: sum of 2 quarters · filed 2021-11-09
-$8.75M
10-Q · filed 2021-11-09
-$7.06M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$4.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$3.53M
10-Q · filed 2021-08-09
-$1.84M
derived: sum of 3 quarters · filed 2022-03-01
$3.80M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$8.47M
10-Q · filed 2021-05-07
-$6.78M
derived: sum of 2 quarters · filed 2022-03-01
-$1.14M
derived: sum of 3 quarters · filed 2022-03-01
$1.23M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$7.33M
derived: sum of 2 quarters · filed 2022-03-01
$9.70M
derived: sum of 3 quarters · filed 2022-03-01
$7.10M
10-K · filed 2022-03-01
2019-09-30$5.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$8.01M
derived: sum of 2 quarters · filed 2020-11-09
$5.41M
10-Q · filed 2020-11-09
$8.49M
derived: sum of 4 quarters · filed 2021-03-16
2019-06-30$2.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$235.00K
10-Q · filed 2020-08-10
$2.85M
derived: sum of 3 quarters · filed 2021-03-16
$3.94M
derived: sum of 4 quarters · filed 2021-03-16
2019-03-31-$2.60M
10-Q · filed 2020-05-11
$476.00K
derived: sum of 2 quarters · filed 2021-03-16
$1.57M
derived: sum of 3 quarters · filed 2021-03-16
$4.22M
derived: sum of 4 quarters · filed 2021-03-16
2018-12-31$3.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$4.18M
derived: sum of 2 quarters · filed 2021-03-16
$6.83M
derived: sum of 3 quarters · filed 2021-03-16
$3.30M
10-K · filed 2021-03-16
$3.30M
10-K · filed 2019-03-18
2018-09-30$1.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$3.75M
derived: sum of 2 quarters · filed 2019-11-07
$222.00K
10-Q · filed 2019-11-07
$222.46K
10-Q · filed 2018-11-07
$1.34M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$2.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$873.00K
10-Q · filed 2019-08-09
-$872.96K
10-Q · filed 2018-08-09
$240.20K
derived: sum of 3 quarters · filed 2020-03-16
$310.36K
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31-$3.52M
10-Q · filed 2019-05-10
-$3.52M
10-Q · filed 2018-05-10
-$2.41M
derived: sum of 2 quarters · filed 2020-03-16
-$2.34M
derived: sum of 3 quarters · filed 2020-03-16
-$4.43M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$1.18M
derived: sum of 2 quarters · filed 2020-03-16
-$901.62K
derived: sum of 3 quarters · filed 2020-03-16
-$4.85M
10-K · filed 2020-03-16
-$4.85M
10-K · filed 2018-03-16
2017-09-30$70.16K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$2.01M
derived: sum of 2 quarters · filed 2018-11-07
-$5.96M
10-Q · filed 2018-11-07
$5.97M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30-$2.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$6.03M
10-Q · filed 2018-08-09
$5.90M
derived: sum of 3 quarters · filed 2019-03-18
$6.86M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31-$3.95M
10-Q · filed 2018-05-10
$7.99M
derived: sum of 2 quarters · filed 2019-03-18
$8.94M
derived: sum of 3 quarters · filed 2019-03-18
$8.75M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31$11.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$12.89M
derived: sum of 2 quarters · filed 2019-03-18
$12.70M
derived: sum of 3 quarters · filed 2019-03-18
$18.28M
10-K · filed 2019-03-18
2016-09-30$955.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$764.88K
derived: sum of 2 quarters · filed 2017-11-07
$6.34M
10-Q · filed 2017-11-07
$7.52M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30-$190.33K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
$5.39M
10-Q · filed 2017-08-07
$6.56M
derived: sum of 3 quarters · filed 2018-03-16
$11.44M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$5.58M
10-Q · filed 2017-05-04
$6.75M
derived: sum of 2 quarters · filed 2018-03-16
$11.63M
derived: sum of 3 quarters · filed 2018-03-16
$14.42M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$1.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$6.05M
derived: sum of 2 quarters · filed 2018-03-16
$8.84M
derived: sum of 3 quarters · filed 2018-03-16
$9.57M
10-K · filed 2018-03-16
2015-09-30$4.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$7.67M
derived: sum of 2 quarters · filed 2016-11-09
$8.39M
10-Q · filed 2016-11-09
$9.10M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$3.51M
10-Q · filed 2016-08-04
$4.22M
derived: sum of 3 quarters · filed 2017-03-16
$1.65M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$724.76K
10-Q · filed 2016-05-09
$1.43M
derived: sum of 2 quarters · filed 2017-03-16
-$1.14M
derived: sum of 3 quarters · filed 2017-03-16
$841.82K
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$705.71K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$1.86M
derived: sum of 2 quarters · filed 2017-03-16
$117.06K
derived: sum of 3 quarters · filed 2017-03-16
-$1.32M
10-K · filed 2017-03-16
2014-09-30-$2.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
-$588.65K
derived: sum of 2 quarters · filed 2015-11-04
-$2.02M
10-Q · filed 2015-11-04
-$2.25M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$1.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03
$544.27K
10-Q · filed 2015-08-03
$315.18K
derived: sum of 3 quarters · filed 2016-03-15
$2.05M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$1.43M
10-Q · filed 2015-05-01
-$1.66M
derived: sum of 2 quarters · filed 2016-03-15
$73.97K
derived: sum of 3 quarters · filed 2016-03-15
-$543.65K
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31-$229.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$1.51M
derived: sum of 2 quarters · filed 2016-03-15
$889.58K
derived: sum of 3 quarters · filed 2016-03-15
$1.92M
10-K · filed 2016-03-15
2013-09-30$1.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
$1.12M
derived: sum of 2 quarters · filed 2014-10-31
$2.15M
10-Q · filed 2014-10-31
$1.34M
derived: sum of 4 quarters · filed 2015-03-16
2013-06-30-$617.62K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$409.26K
10-Q · filed 2014-08-01
-$394.61K
derived: sum of 3 quarters · filed 2015-03-16
$653.67K
derived: sum of 4 quarters · filed 2015-03-16
2013-03-31$1.03M
10-Q · filed 2014-05-09
$223.02K
derived: sum of 2 quarters · filed 2015-03-16
$1.27M
derived: sum of 3 quarters · filed 2015-03-16
$394.63K
derived: sum of 4 quarters · filed 2015-03-16
2012-12-31-$803.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
$244.41K
derived: sum of 2 quarters · filed 2015-03-16
-$632.26K
derived: sum of 3 quarters · filed 2015-03-16
$542.35K
10-K · filed 2015-03-16
2012-09-30$1.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$171.61K
derived: sum of 2 quarters · filed 2013-11-08
$1.35M
10-Q · filed 2013-11-08
-$25.23K
derived: sum of 4 quarters · filed 2014-03-07
2012-06-30-$876.67K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$297.94K
10-Q · filed 2013-08-09
-$1.07M
derived: sum of 3 quarters · filed 2014-03-07
-$180.43K
derived: sum of 4 quarters · filed 2014-03-07
2012-03-31$1.17M
10-Q · filed 2013-05-10
-$196.84K
derived: sum of 2 quarters · filed 2014-03-07
$696.24K
derived: sum of 3 quarters · filed 2014-03-07
$124.95K
derived: sum of 4 quarters · filed 2014-03-07
2011-12-31-$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
-$478.37K
derived: sum of 2 quarters · filed 2014-03-07
-$1.05M
derived: sum of 3 quarters · filed 2014-03-07
-$269.71K
10-K · filed 2014-03-07
2011-09-30$893.08K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
$321.78K
derived: sum of 2 quarters · filed 2012-11-07
$1.10M
10-Q · filed 2012-11-07
$770.48K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$571.29K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$208.66K
10-Q · filed 2012-08-08
-$122.60K
derived: sum of 3 quarters · filed 2013-03-18
$241.45K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$779.95K
10-Q · filed 2012-05-09
$448.69K
derived: sum of 2 quarters · filed 2013-03-18
$812.75K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$331.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$32.80K
derived: sum of 2 quarters · filed 2013-03-18
-$246.88K
10-K · filed 2013-03-18
2010-09-30$364.05K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$84.38K
10-Q · filed 2011-11-04
2010-06-30-$279.67K
10-Q · filed 2011-08-05
2009-12-31-$2.12M
10-K · filed 2012-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60